These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 3706262)
1. Coagulant, fibrinolytic, and aggregating activity in ascitic fluid. Baele G; Rasquin K; Barbier F Am J Gastroenterol; 1986 Jun; 81(6):440-3. PubMed ID: 3706262 [TBL] [Abstract][Full Text] [Related]
2. Bradykinin in the ascitic fluid of patients with liver cirrhosis. Cugno M; Salerno F; Nussberger J; Bottasso B; Lorenzano E; Agostoni A Clin Sci (Lond); 2001 Dec; 101(6):651-7. PubMed ID: 11724653 [TBL] [Abstract][Full Text] [Related]
3. Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease. Agarwal S; Joyner KA; Swaim MW Am J Gastroenterol; 2000 Nov; 95(11):3218-24. PubMed ID: 11095345 [TBL] [Abstract][Full Text] [Related]
4. [Markerfunction of crosslinked fibrin derivatives in ascitic fluid from patients with ovarian cancer: a comparison with ascitic fluid in liver cirrhosis]. Graeff H; Klaubert W; Klaubert E; Gollwitzer R; von Hugo R; Hafter R Geburtshilfe Frauenheilkd; 1983 Jun; 43 Suppl 1():42-6. PubMed ID: 6555132 [TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and Ascites. Thaler J; Lisman T; Quehenberger P; Hell L; Schwabl P; Scheiner B; Bucsics T; Nieuwland R; Ay C; Trauner M; Pabinger I; Reiberger T; Mandorfer M Thromb Haemost; 2022 Mar; 122(3):353-362. PubMed ID: 34020489 [TBL] [Abstract][Full Text] [Related]
6. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Erem C Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444 [TBL] [Abstract][Full Text] [Related]
7. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6. Kruithof EK; Mestries JC; Gascon MP; Ythier A Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401 [TBL] [Abstract][Full Text] [Related]
8. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases. Collatos C; Barton MH; Prasse KW; Moore JN J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947 [TBL] [Abstract][Full Text] [Related]
9. Prevention of coagulopathy after placement of peritoneovenous shunt with replacement of ascitic fluid by normal saline solution. Biagini JR; Belghiti J; Fekete F Surg Gynecol Obstet; 1986 Oct; 163(4):315-8. PubMed ID: 3764636 [TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic characteristics and their significance in malignant, tuberculous and cirrhotic pleural and ascitic fluids. Lu XG; Mao JS; Tong JF; Zhu L; Liu J; Gong XB; Huang J Int J Lab Hematol; 2007 Apr; 29(2):132-8. PubMed ID: 17474886 [TBL] [Abstract][Full Text] [Related]
11. [Coagulation tests in septic surgical patients]. Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805 [TBL] [Abstract][Full Text] [Related]
12. Changes in platelet functions, coagulation and fibrinolysis in uncomplicated cases of acute myocardial infarction. Knudsen JB; Gormsen J; Skagen K; Amtorp O Thromb Haemost; 1980 Feb; 42(5):1513-22. PubMed ID: 6768153 [TBL] [Abstract][Full Text] [Related]
13. Postoperative hypercoagulable state followed by hyperfibrinolysis related to wound healing after hepatic resection. Tsuji K; Eguchi Y; Kodama M J Am Coll Surg; 1996 Sep; 183(3):230-8. PubMed ID: 8784316 [TBL] [Abstract][Full Text] [Related]
14. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis. Stein SF; Harker LA J Lab Clin Med; 1982 Feb; 99(2):217-30. PubMed ID: 7061918 [TBL] [Abstract][Full Text] [Related]
15. Fibrinolytic response to trauma. Kapsch DN; Metzler M; Harrington M; Mitchell FL; Silver D Surgery; 1984 Apr; 95(4):473-8. PubMed ID: 6710342 [TBL] [Abstract][Full Text] [Related]
16. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer. Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184 [TBL] [Abstract][Full Text] [Related]
17. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN. Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653 [TBL] [Abstract][Full Text] [Related]
18. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? Ben-Ari Z; Osman E; Hutton RA; Burroughs AK Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855 [TBL] [Abstract][Full Text] [Related]
19. Anticoagulant activity in cell-free peritoneal fluid of an experimental pancreatic ascites tumor. Ts'ao C; Galluzzo TS; Hart SJ; Ng AS; Sorenson PG; Subbarao V Thromb Haemost; 1985 Dec; 54(4):768-72. PubMed ID: 3003955 [TBL] [Abstract][Full Text] [Related]
20. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels. Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]